



Is self-report sleepiness associated with 
cognitive performance in temporal lobe epilepsy?
A sonolência auto-relatada está associada ao desempenho cognitivo na epilepsia 
do lobo temporal?
Helena Dresch Vascouto1, Maria Emília Rodrigues de Oliveira Thais1, Camila Moreira Osório1, Juliana Ben1, Lucia 
Sukys Claudino1,2, Alexandre Ademar Hoeller1, Hans J. Markowitsch3, Peter Wolf2,4,5, Katia Lin2,4, Roger Walz2,4 
ABSTRACT
Sleepiness and cognitive impairment are common symptoms observed in patients with epilepsy. We investigate whether self-reported 
sleepiness is associated with cognitive performance in patients with refractory mesial temporal lobe epilepsy with hippocampal 
sclerosis (MTLE-HS). Seventy-one consecutive patients with MTLE-HS were evaluated with the Stanford Sleepiness Scale (SSS) before 
neuropsychological evaluation. Their mean SSS scores were compared with controls. Each cognitive test was compared between patients 
with (SSS ≥ 3) or without sleepiness (SSS < 3). Imbalances were controlled by regression analysis. Patients reported a significantly higher 
degree of sleepiness than controls (p < 0.0001). After multiple linear regression analysis, only one test (RAVLT total) remained associated 
with self-reported sleepiness. Conclusion: Self-reported sleepiness was significantly higher in MTLE-HS patients than controls, but did 
not affect their cognitive performance. If confirmed in other populations, our results may have implications for decision making about 
sleepiness screening in neuropsychological settings.
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RESUMO
A sonolência e o comprometimento cognitivo são queixas comuns na epilepsia. Investigamos se a sonolência relatada pelo paciente está 
associada ao desempenho cognitivo na epilepsia do lobo temporal mesial refratária com esclerose do hipocampo (ELTM-EH). 71 pacientes 
com ELTM-EH foram avaliados pela Escala de Sonolência de Stanford (ESS) antes da avaliação neuropsicológica. A média na ESS foi 
comparada com a de controles. Cada teste foi comparado entre os pacientes com sonolência (ESS ≥ 3) ou sem sonolência (ESS <3). Diferenças 
foram controladas por regressão logística múltipla. Os pacientes relataram uma sonolência maior do que os controles (p <0,0001). Após 
a regressão, a sonolência relatada pelos pacientes mostrou-se associada a apenas um teste (RAVLT total). Os pacientes com ELTM-EH 
referem mais sonolência do que os controles, mas esta não foi associada com a cognição. Se confirmado em outras populações, nossos 
resultados implicarão na tomada de decisão sobre o impacto da sonolência no contexto neuropsicológico.
Palavras- chave: testes neuropsicológicos; epilepsia resistente a medicamentos; tomada de decisão clínica.
Mesial temporal lobe epilepsy related to hippocam-
pal sclerosis (MTLE-HS) is the most common focal epi-
lepsy, characterized by seizures that are often refractory to 
antiepileptic drugs (AEDs), as well as being widely referred 
for surgical treatment1. The impact of MTLE-HS conditions 
on a patient’s daily activities and quality of life is extensive, 
increasing psychiatric disorders, cognitive impairments and 
sleep problems2,3.
Patients with epilepsy usually complain of daytime sleepi-
ness,4 which has a serious impact on their quality of life5. This 
symptom reflects a decrease in physiological processes that 
maintain vigilance6 and may arise from a variety of factors 
present in epilepsy, such as acute effects of daytime and noc-
turnal seizures3, polytherapy or daily dose of AEDs7, coexis-
tence of primary sleep disorders8, including abnormalities of 
sleep microarchitecture9 or psychiatric comorbidities10.
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Sleep problems and neuropsychological impairment are 
intrinsically tied to the epilepsy condition. A decrease in 
cognitive performance is highly prevalent in patients with 
MTLE-HS and impacts the domains of memory, language, 
attention, executive functions and nonverbal processes, 
according to the side of the sclerosis or surgical resection11,12. 
Although many studies show a relationship between sleep 
and cognitive performance in different neurological disor-
ders13,14, the literature is scarce regarding this issue in epi-
lepsy, especially when sleepiness and low mental activity are 
common feelings among patients. 
Given that clinical neuropsychologists are concerned 
with the factors associated with cognitive dysfunction, 
undervaluing the existence of sleep problems at the time 
of evaluation may affect the interpretation of neuropsycho-
logical findings15. Recommendations for sleep screening in 
the neuropsychological context include the examination of 
subjective sleepiness, with instruments such as the Stanford 
Sleepiness Scale (SSS), as well as the Epworth Sleepiness 
Scale, to determine the impact on daily activities15. There 
have been no studies investigating whether a self-reported 
sleepiness at the time of evaluation may be useful to predict 
the cognitive performance in patients with epilepsy. 
Understanding the association between the degree of 
sleepiness perceived by the patient and neuropsychological 
findings may have a daily clinical implication: should patient 
perception of sleepiness be considered during the interpre-
tation of cognitive performance? Considering the cognitive 
morbidity that may occur after surgery for MTLE-HS12, the 
use of the perception of sleepiness by the patient as a predic-
tive variable for their cognitive performance may have fur-
ther implications for decision making in epilepsy surgery.
Our hypothesis was that self-reported sleepiness imme-
diately before the neuropsychological evaluation is nega-
tively associated with cognitive performance in patients with 
refractory MTLE-HS. 
METHODS
Patients and presurgical evaluation 
Seventy-one consecutive adults diagnosed with refrac-
tory MTLE-HS were evaluated between August 2008 and 
July 2012, at the Centro de Epilepsia de Santa Catarina. 
Neurologists, neurophysiologists, neurosurgeons, psychia-
trists, nurses and neuropsychologists formed the epilepsy 
surgery team responsible for the patient care. Variables of 
interest were prospectively collected during hospitalization 
of patients for their preoperative evaluation using a proto-
col approved by the Research Ethics Committee Human 
Research of the Federal University of Santa Catarina (No. 515) 
and Governador Celso Ramos Hospital (No. 20012/0007). All 
participants signed an informed consent form and volun-
tarily agreed to participate in this study. 
Drug-resistant epilepsy was defined as the failure to 
respond to at least two AEDs in appropriate doses for at least 
12 months each, with patients having seizures with con-
sciousness impairment. The diagnostic process of MTLE-HS 
was conducted by a full interview, including clinical history, 
neurological examination, psychiatric and neuropsychologi-
cal evaluation, seizure semiology, interictal and ictal video-
EEG analysis, MRI (1.5T) and psychosocial assessment2. All 
patients presented with complex focal seizures with or with-
out epigastric, autonomic or psychic auras.
The MRI showed hippocampal sclerosis characterized by 
a signal increase (FLAIR sequences and T2) and decreased 
hippocampal volume (FLAIR sequence, T1 or T2). Patients 
with asymmetric bilateral abnormalities showed the above-
mentioned findings in one of the hippocampi and atro-
phy or less evident signal abnormalities in the contralateral 
hippocampus.
The clinical and demographic characteristics analyzed 
were: gender, marital status, age, age at epilepsy onset, years of 
education, hand dominance, work activity, hours of sleep dur-
ing the night before evaluation, positive history of a precipitant 
insult, epilepsy duration up to the presurgical assessment, side 
of mesial temporal abnormality and number of AEDs used.
The use of a single AED or one combined with a benzodi-
azepine represented the monotherapy patients. Patients who 
used two or more AEDs, associated or not with benzodiaze-
pines, were classified as being in polytherapy. The AEDs used 
were: phenytoin, carbamazepine, phenobarbital, lamotrigine, 
topiramate, oxcarbazepine, and valproic acid. The benzodiaze-
pines used were clobazam or clonazepam, with chronic admin-
istration. On the first day of hospitalization, patients main-
tained the use of their AEDs. The reduction of the drugs was 
started on the second day, after the evaluation of sleepiness.
For comparisons, the sleepiness levels reported by 
patients were compared with those reported by healthy con-
trols (n = 36). The controls comprised the accompanying per-
sons of patients from other clinics at our university hospital, 
who were matched for age, gender and education level. The 
controls were not related to the MTLE-HS patients included 
in this study.
Sleep evaluation
The Stanford Sleepiness Scale (SSS) is a well-established 
instrument for measuring subjective sleepiness for research 
and clinical purposes, including in patients with epilepsy4,16. 
The instrument was applied immediately before the presur-
gical neuropsychological evaluation as previously described4. 
Participants were instructed to select one of seven descrip-
tors that best described their current state of sleepiness, 
ranging from “alert” to “almost asleep”. The statements and 
their scale values are as follows17: 
1. Feeling active, vital, alert, or wide awake;
2. Functioning at a high level, but not at peak; able 
to concentrate;
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3. Relaxed; awake; not at full alertness; responsive;
4. A little foggy, not at peak; let down;
5. Fogginess; beginning to lose interest in remaining 
awake; slowed down;
6. Sleepiness; prefer to be lying down; fighting sleep; 
woozy; and
7. Almost in reverie; sleep onset soon; lost struggle to 
remain awake.
A score ≥ 3 is associated with a decline in performance 
that is related to sleepiness4. The SSS has sensitivity for sleep 
deprivation18, as well as having a positive correlation with 
sleep latency and a negative correlation with sleep efficiency 
and total sleep time19.
The “hours of sleep overnight” variable was qualitatively 
measured by asking patients about their sleeping hours in 
the night before the cognitive evaluation.
Cognitive tests
The standardized tests were applied by the neuropsycholo-
gist of our team, blinded for all clinical, neurosurgical and labo-
ratory variables previously described. On the first night of hos-
pitalization, the patients were oriented to sleep at 11:00 pm 
and were awakened at 6:00 am on the morning of the cognitive 
evaluation (second day of hospitalization). Neuropsychological 
testing started between 9:00 am and 10:00 am.
The sequence of the tests remained the same in all 
assessments: Category Fluency20, Letters Fluency20, Rey 
Auditory Verbal Learning Test (RAVLT) total and retention20, 
Rey-Osterrieth Complex Figure (ROCF) copy and immedi-
ate recall20, Block Design21, Picture Completion21, RAVLT 
delayed and recognition, ROCF delayed, Logical Memory 1st 
recall and Logical Memory I22, Visual Reproduction I22, Digit 
Span21, Vocabulary21, Matrix Reasoning21, Logical Memory 
II, Visual Reproduction II, Similarities21, Paired Associates 
I22, Information21, Five-Point Test20, Paired Associates II and 
Boston Naming Test20.
Statistical analysis
Continuous variables were expressed as mean ± standard 
deviation (SD) and categorical variables were expressed as 
frequency and percentage values. The Kolmogorov-Smirnov 
test was used to analyze the normal distribution of the vari-
ables. Categorical variables were analyzed by Chi-square or 
Fisher’s exact test.
We compared the mean SSS scores between patients and 
controls using the Student’s “t” test. Based on the SSS score 
dichotomy4,17, the Student’s “t” test was performed to deter-
mine the clinical and demographic differences between patients 
with sleepiness (SSS score ≥ 3) or without sleepiness (SSS < 3), 
as well as comparisons with the cognitive tests. In this analysis, 
we identified the demographic, clinical and cognitive variables 
associated with sleepiness with a level of significance of p < 0.20. 
To exclude whether the association between the neuro-
psychological tests (dependent variable) and the SSS score 
were due to confounding bias related to imbalances in the 
demographic and clinical variables, a multiple linear regres-
sion was done. For this analysis, we included the variables 
showing the association with the SSS with a p < 0.20 level of 
significance.  Considering the clinical and biological plausi-
bility of an association between sleepiness and low cognitive 
performance, to avoid a type II error, a p < 0.05 was consid-
ered significant for our analysis. Because we were unable to 
test the degree of difference between the mean score (and SD) 
of the cognitive test scores in the analyzed groups that could 
be considered clinically meaningful for our patients, the dif-
ference was chosen based arbitrarily on our previous study23. 
In that study, the decrease in the mean score of MTLE-HS 
patients (expressed in percentage of decrease from controls), 
among the cognitive tests showing a statistically signifi-
cant difference between patients and controls, ranged from 
22% ( for RAVLT total) to 49% (RAVLT 49%). In both groups, 
the SD from the mean ranged from 5% to 20% of the mean, 
depending on the cognitive test analyzed. We considered the 
lower percentage of change in the mean (20%) and the high 
percentage of change in the SD (20%) from that study to cal-
culate the power of analysis. The power of our analysis (1-b) 
to detect a difference of 20% in a cognitive test score mean 
(with an SD of 20% of mean) between the patients with (SSS 
score ≥ 3) or without sleepiness (SSS < 3) was 95%.
RESULTS
The demographic characteristics and the SSS scores of 
patients and controls are shown in Table 1. There were no 
differences between patients and controls regarding gender, 
hand dominance, age, years of education and hours of night 
sleep before the SSS evaluation (p > 0.18). Patients had signif-
icantly higher SSS scores than controls (p < 0.0001).  
Table 1. Comparison of demographic variables and the 
Stanford Sleepiness Scale score between patients with 
refractory MTLE-HS and controls.
Variables
Patients Controls
p-valuen = 71 (%) n = 71 (%)
n = 71 (%) n = 36 (%)
Gender
Female 37 (52.1) 23 (63.9)  
Male 34 (47.9) 13 (36.1) 0.25
Hand dominance
Right 66 (93.0) 32 (89)  
Left 5 (7.0) 4 (11) 0.47
Age (years) 36 (11.5) 35.6 (12.3) 0.85
Education (years) 7.3 (3.2) 8.2 (2.8) 0.18
Hours of sleep overnight 6 (2.0) 6.56 (1.7) 0.18
Stanford sleepiness scale
Overall score 3.38 (1.8) 1.56 (0.8) < 0.0001
Score ≥ 3 (%) 33 (46.5) 3 (8.3) < 0.0001
p: significance level.
578 Arq Neuropsiquiatr. 2018;76(9):575-581
Clinical and demographic characteristics of all patients with 
MTLE-HS and their reported level of sleepiness are presented in 
Table 2. Considering all patients, 37 were female (52.1%), an aver-
age age of 36 (± 11.5) years, mean disease duration of 22.7 (± 10.6) 
years, and mean age at epilepsy onset of 9.6 (± 9.1) years. There 
was no significant difference in distribution of gender, marital 
status, work activity, history of initial precipitating injury (brain 
infection, prolonged seizure, prolonged febrile seizure, moderate 
or severe head trauma or labor-related injury), side of hippocam-
pal sclerosis on MRI, hand dominance, age, disease duration, or 
age of epilepsy onset between patients with or without sleepiness 
(p > 0.15). Patients with sleepiness (SSS score ≥ 3) showed nonsig-
nificant trends of higher education levels (p = 0.06), chronic use 
of benzodiazepines (p = 0.10) and lamotrigine (p = 0.06). Patients 
Table 2. The distribution of clinical and demographic variables according to the Stanford Sleepiness Scale (SSS) scores in 









Female 37 (52.1) 13 (35.1) 24 (64.9)  
Male 34 (47.9) 13 (38.2) 21 (61.8) 0.79
Marital status
Single 34 (47.9) 16 (47.1) 18 (52.9)  
Married 26 (36.6) 9 (34.6) 17 (65.4)  
Divorced or widower 7 (9.9) 1 (14.3) 6 (85.7) 0.23
Work activity
Working 22 (31.0) 07 (31.8) 15 (68.2)  
Housewife 13 (18.3) 5 (38.5) 8 (61.5)  
Unemployed 14 (19.7) 4 (28.6) 10 (71.4)  
Health insurance 22 (31.0) 10 (45.5) 12 (54.5) 0.71
History of initial precipitating injury
No 26 (36.6) 8 (30.8) 18 (69.2)  
Yes 38 (53.5) 16 (42.1) 22 (57.9)  
Unknown 7 (9.9) 2 (7.7) 5 (71.4) 0.58
Side of hippocampal sclerosis on MRI
Right 30 (42.3) 9 (30.0) 21 (70.0)  
Left 38 (53.5) 17 (44.7) 21 (55.3)  
Bilateral b 3 (4.2) 0 (0) 3 (100.0) 0.18
AEDs Treatment
Monotherapy 30 (42.3) 12 (40.0) 18 (60.0)  
Polytherapy 41 (57.8) 14 (34.1) 27 (65.8) 0.32
Benzodiazepines
No 32 (45.1) 15 (46.9) 17 (53.1)  
Yes 39 (54.0) 11 (28.2) 28 (71.8) 0.10
AEDs in use 
Carbamazepine 53 (74.6) 17 (32.1) 36 (67.9) 0.17
Phenytoin 11 (15.5) 7 (63.6) 4 (36.4) 0.04
Phenobarbital 19 (26.8) 5 (26.3) 14 (73.7) 0.28
Valproic acid 13 (18.3) 3 (23.1) 10 (76.9) 0.26
Topiramate 5 (7.0) 3 (60.0) 2 (40.0) 0.26
Lamotrigine 10 (14.1) 1 (10.0) 9 (90.0) 0.06
Oxcarbazepine 7 (9.9) 4 (57.1) 3 (42.9) 0.23
Hand Dominance
Right 66 (93.0) 24 (36.4) 42 (63.6)  
Left 5 (7.0) 2 (40.0) 3 (60.0) 0.87
Age (years) 36 (11.5) 35.5 (10) 36.3 (12.3) 0.80
Education (years) 7.3 (3.2) 6.35 (3.3) 7.8 (3.1) 0.06
Disease duration (years) 22.7 (10.6) 22.7 (8.2) 22.7 (11.9) 0.98
Epilepsy onset age (years) 9.6 (9.15) 9.1 (8.5) 9.9 (9.6) 0.73
Hours of sleep overnightc 6 (2.0) 6.9 (1.8) 5.5 (1.96) 0.02
a Sleepiness: Yes: SSS score ≥ 3; No: SSS score < 3; b Bilateral asymmetric hippocampal sclerosis in two patients (right hippocampus worse) and bilateral 
symmetric in one patient; c Hours of overnight sleep on the night before the SSS was evaluated; p: significance level; AEDs: antiepileptic drugs.
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without sleepiness (SSS < 3) reported longer sleep time before 
their evaluation (p = 0.02). Phenytoin treatment was more fre-
quent in the group without sleepiness (p = 0.04). Finally, as seen 
on MRI, distribution of the side of hippocampal sclerosis accord-
ing to reported-sleepiness severity was not significant (p = 0.18).
Comparison of mean scores of each neuropsychological 
test between patients with or without sleepiness is shown 
in Table 3. Among all 25 analyzed neuropsychological tests, 
the RAVLT total (p = 0.01), RAVLT retention (p =0.08), RAVLT 
delayed, ROCF immediate and ROCF delayed were positively 
associated with greater sleepiness with p < 0.20 (Table 3). 
Table 4 shows that after the multiple linear regression 
analysis controlling for benzodiazepines and AEDs used 
(phenytoin, lamotrigine), MRI side of hippocampal sclero-
sis and education level, only the RAVLT total score variation 
remained significantly associated with the SSS score varia-
tion. The SSS score alone predicted 9% (r2 = 0.09, p = 0.01) of 
the RAVLT total score variation.
DISCUSSION
Confirming our previous results4, the patients with drug-
resistant MTLE-HS reported a significantly higher level of sleep-
iness than controls. The non-sleepiness patients (SSS < 3) also 
had more hours of sleep overnight than the sleepiness patients 
(1.4 hours longer), which is consistent with the assumption 
that sleepiness is influenced by sleep duration24. 
However, contrary to our expectations, we found no 
association between the degree of perceived sleepiness and 
cognitive performance in our patients. In addition, a higher 
cognitive performance in the RAVLT test (high scores) was 
observed in the sleepiness group. Since there is no clinical or 
biological plausibility for this association and considering the 
multiple comparisons that we did, this result may be related 
to a type I error.  Even if we assume that the observed signifi-
cant association is real, it has no clinical relevance because: 
i) only one of the 25 neuropsychological tests analyzed could 
Table 3. Neuropsychological tests score of MTLE-HS patients according to sleepiness category determined by the Stanford 





(n = 26) (n = 45)
Verbal memory
Logical Memory 1st 18.4 (7.2) 18.5 (7.5) 0.95
Logical Memory I 29.3 (11.2) 29.9 (11.1) 0.83
Logical Memory II 15.2 (9.9) 15.2 (9.0) 0.99
Paired Associates I 10.2 (6.7) 11.0 (7.3) 0.69
Paired Associates II 2.8 (2.5) 3.5 (2.6) 0.30
RAVLT Total 33 (8.5) 38.4 (8.9) 0.01
RAVLT Retention 5.3 (3.0) 6.6 (2.7) 0.08
RAVLT Delayed 4.7 (3.2) 5.7 (3.0) 0.19
RAVLT Recognition 8.9 (3.9) 10.1 (6.3) 0.37
Nonverbal memory
ROCF Immediate 10.8 (4.7) 13.0 (6.7) 0.15
ROCF Delayed 11.6 (5.1) 14.3 (8.2) 0.13
Visual Reproduction I 61.2 (19.5) 60.7 (21.8) 0.93
Visual Reproduction II 21.9 (19.7) 26 (23.8) 0.46
Attention and working memory
Digit Span 11.6 (2.7) 11 (3.0) 0.37
Executive Function
Five-Points Test 19.1 (11.0) 18.6 (9.5) 0.85
Language
Boston Naming Test 34.1 (9.3) 34.3 (10.1) 0.93
Letters Fluency 20.6 (6.5) 19.5 (8.8) 0.58
Category Fluency 10.4 (3.4) 10.8 (4.4) 0.68
Vocabulary 21.7 (7.9) 22.1 (7.0) 0.83
Similarities 14.1 (5.8) 15.2 (4.5) 0.39
Information 6 (2.8) 6.8 (4.5) 0.32
Visuospatial, visuoperceptual and motor skills
Block Design 21.1 (11.9) 22.8 (12.6) 0.58
Matrix Reasoning 7.8 (4.5) 7.7 (5.1) 0.91
Picture Completion 14.3 (5.0) 14.22 (7.2) 0.94
ROCF Copy 25.4 (6.1) 26.7 (6.5) 0.43
RAVLT: Rey Auditory Verbal Learning Test, ROCF: Rey-Osterrieth Complex Figure.
580 Arq Neuropsiquiatr. 2018;76(9):575-581
be predicted by the SSS; ii) the SSS explained only up to 10% 
of the RAVLT total score variation.
Few studies in epilepsy have highlighted the relation-
ship between sleep problems and cognitive performance25,26. 
Our study differs from those as we investigated the associa-
tion of important patient complaints – feelings of sleepiness 
and cognitive decrease – using a larger sample of MTLE-HS 
patients tested with various instruments covering differ-
ent neuropsychological domains. We challenged the general 
assumption that the degree of sleepiness reported immedi-
ately prior to neuropsychological evaluation would interfere 
with cognitive performance.
As daytime sleepiness is a common feeling among 
patients with epilepsy4,9, the better clinical choice was to 
use self-reporting instruments that measured the percep-
tion of sleepiness at the time, as recommended by Water 
and Bucks15. One hypothesis for our results is that the sub-
jective approach requires that patients be aware of feeling 
sleepy and be able to distinguish sleepiness from other fac-
tors affecting performance6. Depending on the level of som-
nolence, patients are often not quite accurate in estimating 
their own level, sometimes falling asleep while rating them-
selves as fully alert6,27. Preliminary studies have also indi-
cated that contextual factors may influence the subjective 
sleepiness rating, such as the patient’s location and level of 
interest in the activity28. Thus, it is perhaps not totally sur-
prising that a self-reported “sleepiness” before a neuropsy-
chological evaluation did not necessarily result in a cogni-
tive impairment. 
It is possible that stimulation provided by the test condi-
tions itself may have been sufficient to overcome the sleep-
iness initially reported by our patients, partly explaining 
the results found in our samples. A specific decline in cog-
nitive performance may be considered as an indication of 
the level of sleepiness29, but situations presenting interest-
ing, stimulating and engaging tasks are less susceptible to 
decreased performance, while the presence of a low stimu-
lus or low concentration request tend to increase the som-
nolence intensity30. 
The main limitations of our study were the use of only 
one instrument of self-reported sleepiness and the absence 
of a validated Portuguese-language version for use in Brazil. 
The SSS has been recommended in the literature and used 
in national studies for screening acute subjective sleepi-
ness in neuropsychological settings4,9,15, which strongly sup-
ported our choice. In addition, other instruments that mea-
sure subjective sleepiness at the time, such as the Karolinska 
Sleepiness Scale, are not widely used for clinical purposes, 
and even less so in epilepsy research31,32. In spite of the limita-
tions, this study is a step towards understanding which sleep 
complaints may be contributing to the cognitive profile of 
patients. Future studies may complement our results by add-
ing objective measures of sleepiness and subjective analyses 
of previous sleep quality. 
In summary, subjective sleepiness was significantly 
higher in MTLE-HS patients than healthy controls but was 
not associated with their cognitive performance. In conso-
nance with our purposes, the results do not imply that sleep-
iness does not interfere in cognition, but suggest that the 
degree of sleepiness perceived by the patient may be disre-
garded during the interpretation of neuropsychological out-
comes. If confirmed in other populations and epilepsy types, 
our results may have implications for decision making about 
sleepiness screening in clinical settings.
Table 4. Multiple linear regression analysis showing the independent association between the Stanford Sleepiness Scale (SSS) 
scores and the neuropsychological tests.
Cognitive tests and predictors
Linear regression coefficients
p-value
r r2 B (CI 95%)
RAVLT Total 0.46 0.21   0.001
Side of hippocampal sclerosis on MRIa     0.7 (0.1 to 1.4) 0.03
Education     -2.9 (-6.5 to 0.6) 0.10
SSS score     1.2 (0.004 to 2.2) 0.05
SSS score aloneb 0.29 0.09 1.4 (0.3 to 2.6) 0.01
RAVLT Retention 0.46 0.21   0.001
Side of hippocampal sclerosis on MRIa     - 1.5 (-2.6 to -0.36) 0.01
Education     0.2 (- 0.02 to 0.04) 0.07
SSS score     0.25 (-0.1 to 0.6) 0.16
ROCF Delayed 0.42 0.18   0.004
Education     0.3 (0.1 to 0.5) 0.005
SSS     0.28 (-0.6 a 1.2) 0.86
ROCF Immediate 0.39 0.16   0.004
Education     0.8 (0.3 to 1.2) 0.001
SSS score     - 0.2 (-1.0 to 0.6) 0.63
a For the linear regression analysis the side of hippocampal sclerosis on MRI were classified as: 1 = right hippocampal sclerosis; 2 = left hippocampal sclerosis; 
3 = bilateral hippocampal sclerosis; b SSS score alone predicted 9% (r2 = 0.09) of the RAVLT total score variation; p: significance level. RAVLT: Rey Auditory Verbal 
Learning Test, ROCF: Rey-Osterrieth Complex Figure.
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